Elements of cancer immunity and the cancer-immune set point - PubMed (original) (raw)

Review

. 2017 Jan 18;541(7637):321-330.

doi: 10.1038/nature21349.

Affiliations

Review

Elements of cancer immunity and the cancer-immune set point

Daniel S Chen et al. Nature. 2017.

Abstract

Immunotherapy is proving to be an effective therapeutic approach in a variety of cancers. But despite the clinical success of antibodies against the immune regulators CTLA4 and PD-L1/PD-1, only a subset of people exhibit durable responses, suggesting that a broader view of cancer immunity is required. Immunity is influenced by a complex set of tumour, host and environmental factors that govern the strength and timing of the anticancer response. Clinical studies are beginning to define these factors as immune profiles that can predict responses to immunotherapy. In the context of the cancer-immunity cycle, such factors combine to represent the inherent immunological status - or 'cancer-immune set point' - of an individual.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 2011 Aug;121(8):3109-19 - PubMed
    1. Science. 2015 Apr 3;348(6230):80-6 - PubMed
    1. Nat Immunol. 2013 Oct;14(10):1014-22 - PubMed
    1. Curr Genomics. 2008 Sep;9(6):394-408 - PubMed
    1. J Clin Invest. 2015 Sep;125(9):3401-12 - PubMed

Publication types

MeSH terms

LinkOut - more resources